Literature DB >> 12698668

Mechanism of decrease in the atrial potential after implantation of a single-lead VDD pacemaker: atrial histological changes after implantation of a VDD pacemaker lead in dogs.

Yukei Higashi1, Tokutada Sato, Hisa Shimojima, Youichi Takeyama, Ko Goto, Toshiaki Mitsuya, Fumiaki Sagawa, Ryokichi Ishikawa, Yumi Ishikawa.   

Abstract

The single-lead VDD pacemaker system (VDDPS) enables atrial synchronous ventricular pacing with only one lead in patients with an atrioventricular block. There are some cases in which the atrial potential decreases after implantation of a VDDPS, making physiological pacing difficult. The mechanism of this decrease has not been elucidated yet. To elucidate the possible relationship between the decrease of the atrial potential after implantation of a VDDPS and histopathological changes of the atrium. We implanted a VDDPS from the jugular vein under anesthesia in 10 adult dogs. The tip of the pacing lead was fixed in the right ventricular apex of the heart under fluoroscopic guidance. Then, the lead was ligated and fixed to the jugular vein at a point where a favorable atrial potential was obtained. The end of the lead was passed from the neck to the back subcutaneously; then pulled outside and fixed there to measure the atrial potential. The atrial potential was measured using a pacing system analyzer under anesthesia on days 3 (n = 9) and 7 (n = 8), as well as on weeks 2 (n = 6), 3 (n = 4), and 4 (n = 3), after the implantation. The heart was removed from the dogs on day 3 (n = 2), day 7 (n = 2), week 2 (n = 2), and week 4 (n = 4) to examine the atrial histological findings. The atrial potential was 2.7 +/- 0.7 mV at the time of the implantation, 1.7 +/- 1.1 mV (P < 0.05) on day 3, and 1.7 +/- 0.7 mV on week 4 after the implantation. Macroscopically, the pacemaker lead was covered with thrombus, and adhered to the atrial wall in 80% of animals. Microscopically, the endocardium was hypertrophic due to fibrous tissue; besides RBC extravasation, inflammatory cells infiltration and degeneration of myocardial cells, were observed under the endocardium. Inflammatory changes developed in the atrial wall after implantation of the VDDPS, and this seemed to be one of the mechanisms for the decrease of the atrial potential of the VDDPS.

Entities:  

Mesh:

Year:  2003        PMID: 12698668     DOI: 10.1046/j.1460-9592.2003.00118.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  5 in total

1.  Pacemaker lead-related macroreentrant atrial tachycardia.

Authors:  Frederico Scuotto; Maria Cecilia Xavier Souto; Claudio Cirenza; Angelo Amato Vincenzo De Paola
Journal:  Indian Pacing Electrophysiol J       Date:  2022-05-19

2.  The impact of the distance between the atrial electrode and the atrial wall on atrial undersensing in patients with VDD pacemakers: long-term follow-up.

Authors:  Timucin Altin; Muharrem Guldal; Basar Candemir; Cegerhun Polat; Aydan O Ozdemir; Cansin Tulunay; Cagdas Ozdol; Omer Akyurek; Remzi Karaoguz; Cetin Erol
Journal:  Ann Noninvasive Electrocardiol       Date:  2008-10       Impact factor: 1.468

3.  Evolution of paced QRS and QTc intervals in children with epicardial pacing leads.

Authors:  Maren Tomaske; Paul Harpes; Rene Prêtre; Ali Dodge-Khatami; Urs Bauersfeld
Journal:  Clin Res Cardiol       Date:  2007-08-13       Impact factor: 5.460

4.  Biomarkers of Myocardial Injury and Inflammation after Permanent Pacemaker Implantation: The Lead Fixation Type Effect.

Authors:  Dimitrios Varvarousis; Nikolaos Goulas; Kali Polytarchou; Stavroula N Psychari; Konstantinos Paravolidakis; Agapi Konstantinidou; Dionysios Tsoukalas; Delia Vlad; Konstantina Bouki; Athanasios Kotsakis
Journal:  J Atr Fibrillation       Date:  2018-04-30

5.  Long-term outcome in patients receiving permanent pacemaker implantation for atrioventricular block: Comparison of VDD and DDD pacing.

Authors:  Jo-Nan Liao; Tze-Fan Chao; Ta-Chuan Tuan; Chi-Woon Kong; Shih-Ann Chen
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.